medline.ch Respirationstrakt Neoplasie

	Survival outcomes in EGFR-mutant versus wild-type locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy alone in the pre-PACIFIC/LAURA trial era: A systematic review and meta-analysis using reconstructed individual patient data. Cancer Treat Res Commun Ochiai S, Mase T, Toyomasu Y, Takada A, Nomura M, Ii N, Daimon T, Fuwa N, Nomoto Y. PMID: 42419182 [PubMed - as supplied by publisher]
	Prediction of PD-L1 expression in nonsmall cell lung cancer using artificial intelligence models based on radiomics: a systematic review and meta-analysis. Eur Respir Rev Zhang P, Zhang B, Liu N, Huang D, Zhong H, Wu J, Wang Y, Ren Q. PMID: 42419776 [PubMed - indexed for MEDLINE]
	Risk prediction for lung cancer screening: a systematic review and meta-regression. Eur Respir Rev Rezaeianzadeh R, Leung C, Kim SJ, Choy K, Johnson KM, Kirby M, Lam S, Smith BM, Sadatsafavi M. PMID: 42419775 [PubMed - indexed for MEDLINE]
	An Optimization Randomized Clinical Trial to Identify an Effective, Efficient Smoking Cessation Intervention in the Context of Lung Cancer Screening: Cessation and Screening to Save Lives (CASTL). Chest Ostroff JS, Shelley D, Chichester LR, Schofield E, Li Y, Collins LM, Elkin EB, Strayhorn JC, Ciupek A, King JC, Barry A. PMID: 42419585 [PubMed - as supplied by publisher]
	Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer. N Engl J Med Yue D, Huang M, Song P, Chen Y, Li B, Fu J, Guo J, Cheng C, Chen Q, Xu S, Liu H, Lv F, Hu J, Jiang K, Mao W, Shen B, Ye F, Li J, Zhang X, Guo S, Yu B, Zhu Y, Wu M, Zheng W, Chen F, He Z, Bai Y, Xin H, Chen K, Mao N, Zhang Y, Wang B, Zhang L, Chen X, Mei X, Miao L, Wang R, Li G, Yao J, Zhao J, Chen C, Liu J, Wei L, Yan X, Jin B, Liu X, Liu Z, Tian H, Xing W, Yang L, Ge D, Li X, Li S, Song Y, Zang A, Zhang D, Zhuang W, Liu Z, Yuan X, Fu T, Shen Z, Zhang X, Cao Q, Zhao L, Mao L, Ding L, Lu Y, Wang C, ELEVATE Study Group. PMID: 42418775 [PubMed - indexed for MEDLINE]
	Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms. JCO Oncol Pract Carlisle JW, O'Reilly K, Ji XA, Switchenko JM, Steuer CE, Ardeshir-Larijani F, Ramalingam SS, Leal T. PMID: 42418753 [PubMed - as supplied by publisher]
	Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators. J Clin Oncol Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Li T, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL. PMID: 42418737 [PubMed - as supplied by publisher]
	Predicting T790M mutation status in non-small cell lung cancer based on radiomics: A systematic review and meta-analysis. PLoS One Chen H, Fan B, Yuan M, Wang D, Qiao C, Qiu N, Quan X, Hou W. PMID: 42418457 [PubMed - indexed for MEDLINE]
	Cost-Effectiveness of Universal Low-Dose Computed Tomographic Lung Cancer Screening in Singapore. JAMA Netw Open Li R, Abisheganaden J. PMID: 42418200 [PubMed - indexed for MEDLINE]
	Single-Encounter Augmented Reality-Guided Localization for Resection of Suspected Early-Stage Lung Cancer: A Randomized Clinical Trial. JAMA Surg Song Z, Wang Z, Yao H, Tian Q, Liu R, Chen L, Sun M, Ma W, Gong X, Sun C, Xi J, Chen Z, Yu L, Wang Y, Kan CS, Pezzella M, Gao C, Liu H, Cheng X. PMID: 42418181 [PubMed - as supplied by publisher]
	Selection of patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) for long-term follow up of patients diagnosed with lung or rectal cancer. J Patient Rep Outcomes Linmans G, Deneckere S, Lens C, van Poel E, De Gendt C, Sermeus W, De Ridder D. PMID: 42418132 [PubMed - as supplied by publisher]
	Risk prediction of non-small cell lung cancer in patients with pulmonary nodules: a single-center cohort study based on six machine learning algorithms. Clin Transl Oncol Liu Z, Xu X, Zhou S, Fan D, Liu X. PMID: 42418130 [PubMed - as supplied by publisher]
	A Multimodal Strategy for Enhancing Minimally Invasive Ablation of Lung Tumor. Ann Biomed Eng Zhang R, Zhang K, Lou Y, Wang G, Xu LX. PMID: 42417961 [PubMed - as supplied by publisher]
	The Impact of a Menthol Cigarette Ban on Tobacco Use, Lung Cancer, and Life Expectancy. Nicotine Tob Res Mills SD, Tapp-Hughes N, Zhang Y, Ribisl KM, Wiesen CA, Lich KH. PMID: 42417808 [PubMed - as supplied by publisher]
	Clinical Research Progress in the Treatment and Prognosis of Comorbid Coronary Heart Disease and Lung Cancer. Rev Cardiovasc Med Li J, Kang Y, Zhou F, Mu J. PMID: 42416591 [PubMed]
	Predictive value of baseline levels and early dynamic changes of ctDNA for 28-day mortality in ICU patients with advanced lung cancer: a prospective single-center cohort study. Front Mol Biosci Tan L, Lu D, Huang H, Lin D, Zheng D. PMID: 42416486 [PubMed]
	Epithelial and microenvironmental mosaicism under stress: a two-compartment model for lung cancer development in never-smokers. Front Cell Dev Biol Burr R. PMID: 42416117 [PubMed]
	Clinicopathological features and therapeutic advances in primary pulmonary lymphoepithelioma-like carcinoma (Review). Oncol Lett Chen Y, Yu Y, Chen X. PMID: 42416029 [PubMed]
	LungCraft: a hybrid 3D-2D deep learning and radiomics framework with explainable AI for precision diagnosis of lung cancer. Front Artif Intell Kodipyaka N, Suganya G, Johnson DR. PMID: 42415845 [PubMed]
	Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Front Med (Lausanne) Li H, Mi Y, Xu K, Fan M, Yin J, Li Q, Wu Z, Gong C, Jia Y, Gu P, Wei S, Zhang Z, Zhang S, Zheng Y, Lin B, Lang J, Zhao B, Chen M. PMID: 42415804 [PubMed]

Artikel 1 - 20 / 161317

Seite 1 von 8066



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung